Andreas Rimner, M.D.
General Acute Care Hospital
At a glance
- In the NPI registry since
- 2007
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
General Acute Care Hospital primary
NY license P51085
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
| Service | Times | Patients |
|---|---|---|
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 749 | 180 |
| Calculation of radiation therapy dose | 358 | 77 |
| Established patient office or other outpatient visit, 30-39 minutes | 111 | 75 |
| Radiation treatment management, 5 treatment sessions | 111 | 53 |
| Design and construction of complex radiation treatment device | 102 | 86 |
| Design and construction of radiation treatment device for high precision radiation therapy | 82 | 76 |
| High precision radiation therapy planning | 81 | 75 |
| Complex radiation therapy planning | 73 | 69 |
| New patient office or other outpatient visit, 60-74 minutes | 69 | 69 |
| Established patient office or other outpatient visit, 40-54 minutes | 61 | 54 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $29,446 in research payments for these studies, mostly to the institutions running them.
- Stereotactic Body Radiation Therapy with Consolidation Durvalumab in High Risk Early Stage Non Small Cell Lung Cancer a Phase II Single Arm Trial
AstraZeneca Pharmaceuticals LP - A phase I study of olaparib and low dose consolidative thoracic irradiation for extensive stage small cell lung cancer after any response to chemotherapy
AstraZeneca Pharmaceuticals LP
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.